(Q27851728)

30

0 references

D. Neil Hayes

26

D Neil Hayes

0 references

Mohit Butaney

Mohit Butaney

31

0 references

Hiromichi Ebi

Hiromichi Ebi

5

0 references

Yuchuan Wang

Yuchuan Wang

4

0 references

Daniel B Costa

Daniel B Costa

33

0 references

Norman Sharpless

Norman E Sharpless

35

0 references

Andrew L. Kung

Andrew L Kung

41

0 references

Lewis C. Cantley

Lewis C Cantley

40

0 references

Pasi A Jänne

38

Pasi A Jänne

0 references

George D Demetri

37

George D Demetri

0 references

author name string

Zhao Chen

1

0 references

Katherine Cheng

2

0 references

Zandra Walton

3

0 references

Takeshi Shimamura

6

0 references

Yan Liu

7

0 references

Tanya Tupper

8

0 references

Jing Ouyang

9

0 references

Jie Li

10

0 references

Peng Gao

11

0 references

Michele S Woo

12

0 references

Chunxiao Xu

13

0 references

Masahiko Yanagita

14

0 references

Abigail Altabef

15

0 references

Shumei Wang

16

0 references

Charles Lee

17

0 references

Yuji Nakada

18

0 references

Christopher G Peña

19

0 references

Yanping Sun

20

0 references

Yoko Franchetti

21

0 references

Catherine Yao

22

0 references

Amy Saur

23

0 references

Michael D Cameron

24

0 references

Mizuki Nishino

25

0 references

Matthew D Wilkerson

27

0 references

Patrick J Roberts

28

0 references

Carrie B Lee

29

0 references

Lucian R Chirieac

32

0 references

David Jackman

34

0 references

Diego H Castrillon

36

0 references

Jeffrey A Engelman

42

0 references

Kwok-Kin Wong

Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors

43

0 references

language of work or name

English

0 references

publication date

18 March 2012

0 references

1 reference

483

0 references

page(s)

613-7

0 references

issue

7391

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Characterizing the cancer genome in lung adenocarcinoma

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

LKB1 modulates lung cancer differentiation and metastasis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer

24 May 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

How genetically engineered mouse tumor models provide insights into human cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Prognosis and reevaluation of lung cancer by positron emission tomography imaging

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the Europ

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Prevalence and specificity of LKB1 genetic alterations in lung cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

A phase II, open-label, randomized study to assess the efficacy and safety of AZD6244 (ARRY-142886) versus pemetrexed in patients with non-small cell lung cancer who have failed one or two prior chemotherapeutic regimens

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385933

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study

2 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNATURE10937

Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNATURE10937

Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNATURE10937

Translational medicine: Cancer lessons from mice to humans

21 January 2018

1 reference

12 December 2020

Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere)

1 reference

12 December 2020

Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group

1 reference

12 December 2020

Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models

1 reference

12 December 2020

Identifiers

DOI

10.1038/NATURE10937

1 reference

Dimensions Publication ID

3651406

1012742558

0 references

Fatcat ID

release_w65zpy2hsrbc7pmpvd74vvzaiq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w65zpy2hsrbc7pmpvd74vvzaiq

24 November 2022

mapped directly with Wikidata item

3651406

1 reference

1 reference

1 reference